IS:MARKSANS Marksans Pharma Limited

Marksans Pharma Limited, together with its subsidiaries, researches, develops, manufactures, and markets and distributes generic pharma solutions in North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers analgesics, expectorants, antidiabetic, cardiovascular, central nervous system, gastrointestinal, and oncologic drugs, as well as antibiotics and anti-allergics. It also provides contract research and manufacturing services; and develops and out-licenses patented products. The company was incorporated in 1992 and is headquartered in Mumbai, India.

58.95 INR
As of 01/21/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-General
Index country:  India
Country of incorporation:  India
IPO date:  07/19/2002
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   24,129,058,816 INR
Current dividend yield:   0.42%
Sedol:      6327479

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy